Literature DB >> 228093

Systemic absorption and sustained effects of vaginal estrogen creams.

P L Martin, S S Yen, A M Burnier, H Hermann.   

Abstract

Systemic absorption and sustained effects of two estrogen vaginal cream preparations (Premarin and Estrace) were measured in 29 postmenopausal women receiving daily applications. With both preparations, vaginal absorption of estrogens into the systemic circulation was rapid, efficient, and sustained. It is apparent that estrogen vaginal cream preparations, as widely used in clinical practice for their local effects on the vaginal mucosa, actually result in sustained high estrogen levels in the systemic circulation. The vaginal route shows promise when systemic estrogen therapy is indicated, but is dangerous when estrogen is contraindicated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228093

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

Review 1.  Current status of postmenopausal oestrogen therapy.

Authors:  R L Young; J W Goldzieher
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

2.  Evaluation of the effects of a new intravaginal gel, containing purified bovine colostrum, on vaginal blood flow and vaginal atrophy in ovariectomized rat.

Authors:  Silvia Vailati; Elsa Melloni; Ermanno Riscassi; Delphine Behr Roussel; Marco Sardina
Journal:  Sex Med       Date:  2013-12       Impact factor: 2.491

3.  Challenges of Managing Lower Urinary Tract Symptoms in Women with Tamoxifen Use.

Authors:  Ethan M Fan; Philippe E Zimmern
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-04-11

4.  Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy.

Authors:  Lisa A Chism
Journal:  Int J Womens Health       Date:  2012-10-12

5.  A case of extrauterine endometrial stromal sarcoma in the colon diagnosed three decades after hysterectomy for benign disease.

Authors:  Andres Ayuso; Oluwole Fadare; Dineo Khabele
Journal:  Case Rep Obstet Gynecol       Date:  2013-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.